SI-2

CAS No. 223788-33-8

SI-2( —— )

Catalog No. M34423 CAS No. 223788-33-8

SI-2 is an inhibitor (SMI) of steroid receptor coactivator-3 (SRC-3 or AIB1).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 603 Get Quote
5MG 922 Get Quote
10MG 1226 Get Quote
25MG 1794 Get Quote
50MG 2410 Get Quote
100MG 3177 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SI-2
  • Note
    Research use only, not for human use.
  • Brief Description
    SI-2 is an inhibitor (SMI) of steroid receptor coactivator-3 (SRC-3 or AIB1).
  • Description
    SI-2 is an inhibitor (SMI) of steroid receptor coactivator-3 (SRC-3 or AIB1). SI-2 can selectively reduce the transcriptional activities and the protein concentrations of SRC-3 in cells, and selectively induce breast cancer cell death with IC50 values in the low nanomolar range (3-20 nM), but not affect normal cell viability.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    223788-33-8
  • Formula Weight
    265.31
  • Molecular Formula
    C15H15N5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1C=2C(N=C1NN=C(C)C3=CC=CC=N3)=CC=CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Stearamide

    Stearamide(Stearic acid amide) is a primary fatty acid amide that is cytotoxic and fish toxic and can be used to increase the properties of nanoparticles.

  • Alismol

    Alismol has antihypertensive action, it decreases cardiac output, heart rate and left ventricular pressure, but it increases coronary flow, it has been used for the prevention of anginal attacks.

  • Pueroside B

    Pueroside B may can treat coronary heart disease, it can interact with two or more targets[peroxisome proliferator activated receptor γ (PPAR-γ), angiotensin-converting enzyme (ACE), hydroxymethylglutaryl coenzyme A receptor (HMGR), cyclooxygenase-2 (COX2), and thrombin].